← back to search

Zhuangzhong Chen

Guangzhou University of Chinese Medicine · CN
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Hepatocellular carcinoma, Cell growth, Decoction, PI3K/AKT/mTOR pathway, and Protein kinase B.
h-index
citations
132
works
13
NIH funding
primary concept
email

Recent publications

Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model
BMC Complementary Medicine and Therapies 2025cited by 0position: middledoi
Clinical Efficacy of Hexue Tongbi Formula on Oxaliplatin-Induced Peripheral Neuropathy: A Randomized Controlled Study
Integrative Cancer Therapies 2024cited by 1position: middledoi
Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis
Chinese Medicine 2022cited by 24position: middledoi
Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p/PDL1.
PubMed 2022cited by 10position: middledoi
Research Trend of Publications Concerning Antibody-Drug Conjugate in Solid Cancer: A Bibliometric Study
Frontiers in Pharmacology 2022cited by 8position: middledoi
Efficacy of sintilimab and fruquintinib combination treatment in the management of microsatellite-stable metastatic colorectal cancer: a case report
Annals of Translational Medicine 2022cited by 8position: middledoi
Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction Suppresses Cell Proliferation and Induced Cell Apoptisis in Hepatocellular Carcinoma via PI3K/Akt/P53/FoxO Signaling Axis
Research Square 2022cited by 1position: middledoi
Additional file 2 of Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis
Open MIND 2022cited by 0position: middledoi
Additional file 3 of Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis
Figshare 2022cited by 0position: middledoi
A Data Mining-Based Analysis of Core Herbs on Different Patterns (Zheng) of Non-Small Cell Lung Cancer
Evidence-based Complementary and Alternative Medicine 2021cited by 14position: middledoi
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
International Journal of General Medicine 2021cited by 7position: middledoi
Yiqi Chutan Tang Reduces Gefitinib‐Induced Drug Resistance in Non‐Small‐Cell Lung Cancer by Targeting Apoptosis and Autophagy
Cytometry Part A 2019cited by 19position: middledoi
Cp*Co(<scp>iii</scp>)-Catalyzed oxidative [5+2] annulation: regioselective synthesis of 2-aminobenzoxepines <i>via</i> C–H/O–H functionalization of 2-vinylphenols with ynamides
Chemical Communications 2018cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hanhan Li · Guangzhou University of Chinese Medicine5 papers (2022–2025)Hanrui Chen · Guangzhou University of Chinese Medicine5 papers (2022–2025)Xiaohui Yao · Guangzhou University of Chinese Medicine4 papers (2022–2022)Siyuan Lan · Guangzhou University of Chinese Medicine4 papers (2022–2022)Guanxian Liu · Sun Yat-sen Memorial Hospital4 papers (2022–2022)Wei Guo · Gansu Agricultural University3 papers (2022–2022)Xiangjun Qi · Guangzhou University of Chinese Medicine3 papers (2021–2022)Shan Liu · Shandong University2 papers (2022–2022)Ling Yu · Beijing Forestry University2 papers (2022–2022)Lizhu Lin · Guangzhou University of Chinese Medicine2 papers (2021–2021)Lizhu Lin · Sun Yat-sen University Cancer Center2 papers (2019–2025)Wen‐Ming Chen · National University of Singapore2 papers (2021–2021)Lin Yuan · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2022)Wei Guo · Fudan University1 papers (2022–2022)De Li Liu · Guangzhou University of Chinese Medicine1 papers (2022–2022)Mengquan Li · Guangzhou University of Chinese Medicine1 papers (2022–2022)En‐Ze Lin · Tsinghua University1 papers (2018–2018)Jiaqi Liang · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2022–2022)Jingyu Feng · Guangzhou University of Chinese Medicine1 papers (2024–2024)Honggen Wang · Sun Yat-sen University1 papers (2018–2018)